Biocon Limited has informed the Exchange about press release dated 01-Apr-2022 titled 'Biocon Biologics��� Partner Receives Positive EU CHMP Opinion for Biosimilar Human Insulin for IV Infusion'.
Press Release Apr 01 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Biocon
- Press Release Mar 29 2022
- Press Release Mar 23 2022
- Press Release Jan 20 2022
- Press Release Dec 30 2021
- Press Release Dec 23 2021
Later from Biocon
- Press Release Apr 26 2022
- Press Release Apr 28 2022
- Press Release May 19 2022
- Press Release Jun 09 2022
- Press Release Jul 27 2022
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon